New research suggests a concerning coronavirus variant first identified in South Africa diminished Pfizer and Moderna’s vaccine-induced antibody levels, and the protection is unclear.
New research suggests a concerning coronavirus variant first identified in South Africa diminished Pfizer and Moderna’s vaccine-induced antibody levels, and the protection is unclear.